Search Results - "Dickinson, Roger P"

Refine Results
  1. 1

    A Potent, Selective Inhibitor of Matrix Metalloproteinase-3 for the Topical Treatment of Chronic Dermal Ulcers by Fray, M. Jonathan, Dickinson, Roger P, Huggins, John P, Occleston, Nicholas L

    Published in Journal of medicinal chemistry (31-07-2003)
    “…The pathology of chronic dermal ulcers is characterized by excessive proteolytic activity which degrades extracellular matrix (required for cell migration) and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    A novel series of highly selective inhibitors of MMP-3 by Whitlock, Gavin A., Dack, Kevin N., Dickinson, Roger P., Lewis, Mark L.

    Published in Bioorganic & medicinal chemistry letters (15-12-2007)
    “…The design and synthesis of a series of highly selective hydroxamate inhibitors of MMP-3 is described. Substitution of a 4-biaryl piperidine sulfonamide core…”
    Get full text
    Journal Article
  5. 5

    Absorption, Distribution, Metabolism, and Excretion Considerations in Selection of Orally Active Indole-Containing Endothelin Antagonist by WALKER, Donald K, DACK, Kevin N, DICKINSON, Roger P, FENNER, Katherine S, JAMES, Kim, RAWSON, David J, SMITH, Dennis A

    Published in Drug metabolism and disposition (01-11-2001)
    “…A series of potent indole-containing endothelin antagonists were evaluated in rat pharmacokinetic studies as part of a rational drug design program. Early…”
    Get full text
    Journal Article
  6. 6

    Thromboxane Modulating Agents. 3. 1H-Imidazol-1-ylalkyl- and 3-Pyridinylalkyl-Substituted 3-[2-[(Arylsulfonyl)amino]ethyl]benzenepropanoic Acid Derivatives as Dual Thromboxane Synthase Inhibitor/Thromboxane Receptor Antagonists by Dickinson, Roger P, Dack, Kevin N, Long, Clive J, Steele, John

    Published in Journal of medicinal chemistry (10-10-1997)
    “…The design of a series of dual thromboxane synthase inhibitor/thromboxane receptor antagonists based on a 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid…”
    Get full text
    Journal Article
  7. 7

    Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-Isoquinolinylguanidines by Barber, Christopher G., Dickinson, Roger P., Fish, Paul V.

    Published in Bioorganic & medicinal chemistry letters (21-06-2004)
    “…A series of 1-isoquinolinylguanidines are selective inhibitors of uPA. Compound 13j (UK-356,202) combines excellent potency and selectivity, and has been…”
    Get full text
    Journal Article
  8. 8

    Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 2: (3-Substituted-5-halo-2-pyridinyl)guanidines by Barber, Christopher G, Dickinson, Roger P

    Published in Bioorganic & medicinal chemistry letters (21-01-2002)
    “…Based on previous modeling predictions, a series of (3-substituted-5-chloro-2-pyridinyl)guanidines have been designed with good potency and selectivity for…”
    Get full text
    Journal Article
  9. 9

    Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines by Barber, Christopher G, Dickinson, Roger P, Horne, Valerie A

    Published in Bioorganic & medicinal chemistry letters (21-01-2002)
    “…The identification of 2-pyridinylguanidines (e.g., 27 and 28) as selective inhibitors of urokinase-type plasminogen activator (uPA) is described. The X-ray…”
    Get full text
    Journal Article
  10. 10

    Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3′ group chirality by Fray, M.Jonathan, Burslem, M.Frank, Dickinson, RogerP

    Published in Bioorganic & medicinal chemistry letters (26-02-2001)
    “…Structure–activity relationships are described for a series of succinyl hydroxamic acids 1a– o and their carboxylic acid analogues 2a– o as inhibitors of…”
    Get full text
    Journal Article
  11. 11

    Selective thromboxane synthetase inhibitors. 3. 1H-Imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene- and indole-2- and 3-carboxylic acids by Cross, Peter E, Dickinson, Roger P, Parry, M. John, Randall, Michael J

    Published in Journal of medicinal chemistry (01-09-1986)
    “…The preparation of a series of 1H-imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene-, and indolecarboxylic acids is described. Most of the compounds…”
    Get full text
    Journal Article
  12. 12

    Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent by Gwilt, M, Dalrymple, H W, Burges, R A, Blackburn, K J, Dickinson, R P, Cross, P E, Higgins, A J

    Published in Journal of cardiovascular pharmacology (01-03-1991)
    “…A class III antiarrhythmic agent that preferentially increases the effective refractory period without altering conduction velocity holds considerable promise…”
    Get more information
    Journal Article
  13. 13

    Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles by Cross, Peter E, Dickinson, Roger P, Parry, M. John, Randall, Michael J

    Published in Journal of medicinal chemistry (01-10-1985)
    “…1-(2-Phenoxyethyl)-1H-imidazole was found to be an inhibitor of thromboxane (TxA2) synthetase, but it also inhibited the adrenal cytochrome P-450 enzyme…”
    Get full text
    Journal Article
  14. 14

    Selective thromboxane synthetase inhibitors. 2. 3-(1H-Imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogs by Cross, Peter E, Dickinson, Roger P, Parry, M. John, Randall, Michael J

    Published in Journal of medicinal chemistry (01-03-1986)
    “…The preparation of a series of 3-(1H-imidazol-1-ylmethyl)-1H-indole-1-alkanoic acids is described. Several compounds were found to be more potent thromboxane…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Promotion of carbohydrate oxidation in the heart by some phenylglyoxylic acids by Barnish, Ian T, Cross, Peter E, Danilewicz, John C, Dickinson, Roger P, Stopher, David A

    Published in Journal of medicinal chemistry (01-04-1981)
    “…A series of phenylglyoxylic acids is described, many of which are able to promote carbohydrate oxidation in muscle tissue, thereby favorably altering the…”
    Get full text
    Journal Article
  17. 17

    Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 2. Imidazo[2,1-b]thiadiazole and imidazo[2,1-b]thiazolesulfonamides by Barnish, Ian T, Cross, Peter E, Dickinson, Roger P, Gadsby, Brian, Parry, Michael J, Randall, Michael J, Sinclair, Ian W

    Published in Journal of medicinal chemistry (01-02-1980)
    “…A series of imidazo[2,1-b]thiadiazole and imidazo[2,1-b]thiazolesulfonamide carbonic anhydrase inhibitors is described and their anticonvulsant activities are…”
    Get full text
    Journal Article
  18. 18

    Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5-(Arylthio)-, 5-(arylsulfinyl)-, and 5-(arylsulfonyl)thiophene-2-sulfonamides by Barnish, Ian T, Cross, Peter E, Dickinson, Roger P, Parry, Michael J, Randall, Michael J

    Published in Journal of medicinal chemistry (01-08-1981)
    “…A series of 5-(arylthio)-, 5-(arylsulfinyl)-, and 5-(arylsulfonyl)thiophene-2-sulfonamides is described and anticonvulsant activities are listed for the…”
    Get full text
    Journal Article
  19. 19

    Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (Stromelysin-1) by Fray, M.Jonathan, Dickinson, RogerP

    Published in Bioorganic & medicinal chemistry letters (26-02-2001)
    “…Structure–activity relationships are described for a series of succinyl hydroxamic acids 4a– o as potent and selective inhibitors of matrix metalloprotease-3…”
    Get full text
    Journal Article
  20. 20

    Novel antifungal 2-aryl-1-(1 H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity against Aspergillus fumigatus by Dickinson, Roger P., Bell, Andrew S., Hitchcock, Christopher A., Narayanaswami, Subramaniyan, Ray, Stephen J., Richardson, Kenneth, Troke, Peter F.

    Published in Bioorganic & medicinal chemistry letters (20-08-1996)
    “…Replacement of one triazole ring of fluconazole with 4-pyridinyl leads to an increase in activity against Aspergillus fumigatus. Introduction of an α-methyl…”
    Get full text
    Journal Article